Allogeneic stem cell transplantation for treatment of immunodeficiency

Springer Seminars in Immunopathology

Volumn 26, Issue 1-2, 2004, Pages 109-118

  Friedrich, Wilhelm ^a   Müller, Susanna M ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Allogeneic stem cells; Immunodeficiencies; Transplantation

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; CYTOREDUCTIVE SURGERY; HUMAN; IMMUNE DEFICIENCY; IN UTERO STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

FEMALE; FETAL DISEASES; FETAL THERAPIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; PREGNANCY; SEVERE COMBINED IMMUNODEFICIENCY; TRANSPLANTATION, HOMOLOGOUS;

EID: 11144281398     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-004-0158-2     Document Type: Review

References (39)

1. Antoine C, Friedrich W, Cant A, et al (2003) Long term survival and hematopoietic stem-cell transplantation for immunodeficiencies. A survey of the European experience 1968-99. Lancet 361:553-560
2. Bach FH, Albertini RJ, Anderson JL, et al (1968) Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet II:1364-1366
3. Bertrand Y, Landais P, Friedrich W, et al (1999) Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the European society for immunodeficiency. J Pediatr 134:740-748
4. Blaese RM, Culver KW, Miller AD, et al (1995) T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 270:475-480
5. Brochstein JA, Gillio AP, Ruggiero M, et al (1991) Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for corrections for Wiskott-Aldrich syndrome. J Pediatr 119:907-912
6. Buckley RH (2000) Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 343:1313-1324
7. Buckley RH, Schiff SE, Schiff RI, et al (1999) Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 340:508-516
8. Candotti F, Notarangelo L, Visconti R, et al (2002) Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways. J Clin Invest 109:1261-1269
9. Cavazzana-Calvo M, Hacein-Bey S, Saint Basile G de, et al (2000) Gene therapy of human severe combined immunodeficiency (SCID)-Xl disease. Science 288:669-672
10. Fischer A (2000) Severe combined immunodeficiencies (SCID). Clin Exp Immunol 122:143-149
11. Fischer A (2001) Primary immunodeficiency diseases: an experimental model for molecular medicine. Lancet 357:1863-1869
12. Fischer A, Landais P, Friedrich W, et al (1990) European experience of bone marrow transplantation for severe combined immunodeficiency. Lancet 336:850-854
13. Fischer A, Landais P, Friedrich W, et al (1994) Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for immunodeficiency. Blood 83:1149-1154
14. Fischer A, Hacein-Bey S, Cavazzana-Calvo M (2002) Gene therapy of severe combined immunodeficiencies. Nat Rev Immunol. 2:615-621
15. Filipovich AH, Stone JV, Tomany SC, et al (2001) Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 97:1598-1603
16. Flake AW, Zanjani ED (1999) In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood 94:2179-2191
17. Friedrich W, Goldmann SF, Vetter U, et al (1984) Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow. Lancet I:761-764
18. Friedrich W, Goldmann SF, Ebell W, et al (1985) Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors. Eur J Pediatr 144:125-130
19. Gatti RA, Meeuwissen HJ, Allen HD, et al (1968) Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet II:1366-1369
20. Haddad E, Landais P, Friedrich W, et al (1998) Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 91:3646-3653
21. Horwitz ME, Barrett AJ, Brown MR et al (2001) Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 344:881-888
22. Kane L, Gennery AR, Crooks BN, et al (2001) Neonatal bone marrow transplantation for severe combined immunodeficiency. Arch Dis Child Fetal Neonatal Ed 85:F110-113
23. Kapoor N, Kirkpatrick D, Blaese RM, et al (1981) Reconstitution of normal megakaryocytopoiesis and immunological functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide. Blood 57:692-696
24. Macchi P, Villa A, Giliani S, et al (1995) Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65-68
25. Moshous D, Callebaut I, Chasseval R de, et al (2001) Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105:177-186
26. Müller SM, Ege M, Pottharst A, et al (2001) Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 98:1847-1851
27. Noguchi M, Yi H, Rosenblatt HM, et al (1993) Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147-57
28. O'Reilly RJ, Small TN, Friedrich W (2004) Hematopoietic cell transplant for immunodeficiency diseases. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic cell transplantation, 2nd edn. Blackwell Science, Malden, pp 1430-1442
29. Ozsahin H, LeDeist F, Benkerrou M, et al (1996) Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. J Pediatr 129:238-244
30. Patel DD, Gooding ME, Parrott RE, et al (2000) Thymic function after haematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl Med J 342:1325-1332
31. Persis A, Gaspar HB, Hassan A, et al (2000) Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 96:1239-1245
32. Pollack S, Kirckpatrick D, Kapoor N, et al (1982) Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 307:662-665
33. Puck JM, Deschenes SM, Porter JC, et al (1993) The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 2:1099-1104
34. Reisner Y, Kapoor N, Kirkpatrick D, et al (1983) Transplantation for severe combined immunodeficiency HLA-A, B, D, DR incompatible parental marrow fractionated by soybean agglutinin and sheep red blood cells. Blood 61:341-348
35. Russell SM, Tayebi N, Nakajima H, et al (1995) Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid devlopment. Science 270:797-800
36. Sarzotti M, Patel DD, Li X, et al (2003) T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation. J Immunol 170:2711-2718
37. Schwarz K, Gauss GH, Ludwig L, et al (1996) RAG mutations in human B cell-negative SCID. Science 274:97-99
38. Thrasher AJ, Kinnon C (2000) The Wiskott-Aldrich syndrome. Clin Exp Immunol 120:2-9
39. WHO Scientific Group Report (1999) Primary immunodeficiency diseases. Clin Exp Immunol 118: 1-34